FRESENIUS MEDICAL CARE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.72 EUR | -0.81% |
|
+7.58% | +9.91% |
| May. 16 | Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability | MT |
| May. 15 | Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 19.58B 21.26B | Sales 2025 * | 20.32B 22.07B | Capitalization | 12.24B 13.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 654M 710M | Net income 2025 * | 964M 1.05B | EV / Sales 2024 * | 1.13 x |
| Net Debt 2024 * | 9.92B 10.77B | Net Debt 2025 * | 8.98B 9.76B | EV / Sales 2025 * | 1.04 x |
| P/E ratio 2024 * |
19.4
x | P/E ratio 2025 * |
12.8
x | Employees | 117,128 |
| Yield 2024 * |
2.66% | Yield 2025 * |
3.12% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | -0.81% | ||
| 1 week | +7.89% | ||
| Current month | +5.35% | ||
| 1 month | +17.85% | ||
| 3 months | +7.53% | ||
| 6 months | +17.62% | ||
| Current year | +9.91% |
1 week
39.08
42.12
1 month
34.8942.12
Current year
33.8842.12
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 41.72 | -0.81% | 786,412 |
| 24-05-15 | 42.06 | +2.21% | 649,796 |
| 24-05-14 | 41.15 | +1.66% | 487,287 |
| 24-05-13 | 40.48 | +0.20% | 523,781 |
| 24-05-10 | 40.4 | +4.18% | 637,324 |
Delayed Quote Xetra, May 16, 2024 at 11:38 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-16
- Ex-dividend day for final dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
41.72
EUR
Average target price
39.48
EUR
Spread / Average Target
-5.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.91% | 13.41B | |
| +19.22% | 85.64B | |
| -27.14% | 70.63B | |
| +4.65% | 27.05B | |
| -6.23% | 17.97B | |
| +1.60% | 17.58B | |
| +3.30% | 15.64B | |
| +7.44% | 13.55B | |
| +73.32% | 13.18B | |
| +69.26% | 12.99B |
- Stock Market
- Equities
- FME Stock